HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, MD, MPH, would seemingly like us to believe that they are strong-arming pharmaceutical companies into ending misleading marketing ...

Critics have railed against direct-to-consumer ads for prescription drugs since the 1990s. Opponents of the ads, many of whom are medical providers, say they contribute to unnecessary anxiety and self ...

Rulemaking to remove its longstanding “adequate provision” framework, described as a “loophole” undermining “informed patient consent” that has allegedly enabled companies to “hide safety information.